Current strategies in the search for low penetrance genes in cancer

Histology and Histopathology

Volumn 23, Issue 4, 2008, Pages 507-514

  Milne, Roger L ^a   Benítez, Javier ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Cancer; Genes; SNPs; Study design

Indexed keywords

EID: 84863980509     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Abelson J.F., Kwan K.Y., O'Roak B.J., Baek D.Y., Stillman A.A., Morgan T.M., Mathews C.A., Pauls D.L., Rasin M.R., Gunel M., Davis N.R., Ercan-Sencicek A.G., Guez D.H., Spertus J.A., Leckman J.F., Dure L. St, Kurlan R., Singer H.S., Gilbert D.L., Farhi A., Louvi A., Lifton R.P., Sestan N. and State MW. (2005). Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320.
2. Antoniou A.C. and Easton D.F. (2003). Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol. 25, 190-202.
3. Beohar N. and Kawamoto S. (1998). Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene. Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type-and differentiation state-dependent manner. J. Biol. Chem. 273, 9168-9178.
4. Botstein D. and Risch N. (2003). Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33 Suppl, 228-237.
5. Breast Cancer Association Consortium. (2006). Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J. Natl. Cancer Inst. 98, 1382-1396.
6. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., Lindblom A., Tannergard P., Bollag R.J., Godwin A.R., Ward D.C., Nordenskjold M., Fishel R., Kolodner R. and Liskay R.M. (1994). Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 368, 258-261.
7. Cannon-Albright L.A., Goldgar D.E., Meyer L.J., Lewis C.M., Anderson D.E., Fountain J.W., Hegi M.E., Wiseman R.W., Petty E.M., Bale A.E., Olopade O.I., Diaz M.O., Kwiatkowski D.J., Piepkorn M.W., Zone J.J. and Skolnick M.H. (1992). Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258, 1148-1152.
8. Cardon L.R. and Bell J.I. (2001). Association study designs for complex diseases. Nat. Rev. Genet. 2, 91-99.
9. Carlson C.S., Eberle M.A., Kruglyak L. and Nickerson D.A. (2004). Mapping complex disease loci in whole-genome association studies. Nature 429, 446-452.
10. Clop A., Marcq F., Takeda H., Pirottin D., Tordoir X., Bibe B., Bouix J., Caiment F., Elsen J.M., Eychenne F., Larzul C., Laville E., Meish F., Milenkovic D., Tobin J., Charlier C. and Georges M. (2006). A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet. 38, 813-818.
11. Cox A., Dunning A.M., Garcia-Closas M., Balasubramanian S., Reed M.W., Pooley K.A., Scollen S., Baynes C., Ponder B.A., Chanock S., Lissowska J., Brinton L., Peplonska B., Southey M.C., Hopper J.L., McCredie M.R., Giles G.G., Fletcher O., Johnson N., Dos Santos Silva I., Gibson L., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Torres D., Hamann U., Justenhoven C., Brauch H., Chang-Claude J., Kropp S., Risch A., Wang-Gohrke S., Schurmann P., Bogdanova N., Dork T., Fagerholm R., Aaltonen K., Blomqvist C., Nevanlinna H., Seal S., Renwick A., Stratton M.R., Rahman N., Sangrajrang S., Hughes D., Odefrey F., Brennan P., Spurdle A.B., Chenevix-Trench G., Beesley J., Mannermaa A., Hartikainen J., Kataja V., Kosma V.M., Couch F.J., Olson J.E., Goode E.L., Broeks A., Schmidt M.K., Hogervorst F.B., Veer L.J., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Wedren S., Hall P., Low Y.L., Liu J., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Sigurdson A.J., Stredrick D.L., Alexander B.H., Struewing J.P., Pharoah P.D. and Easton D.F. (2007). A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 39, 352-358.
12. Cox D.G., Hankinson S.E. and Hunter D.J. (2006). Polymorphisms in the ICAM gene locus are not associated with breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 15, 178-179.
13. Chamary J.V., Parmley J.L. and Hurst L.D. (2006). Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat. Rev. Genet. 7, 98-108.
14. Daimon M., Ji G., Saitoh T., Oizumi T., Tominaga M., Nakamura T., Ishii K., Matsuura T., Inageda K., Matsumine H., Kido T., Htay L., Kamatani N., Muramatsu M. and Kato T. (2003). Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem. Biophys. Res. Commun. 302, 751-758.
15. Dean G. and Clark I.M. (1999). Transcriptional regulation of the human tissue inhibitor of metalloproteinases-1: mapping transcriptional control in intron-1. Ann. NY Acad. Sci. 878, 510-511.
16. Dermitzakis E.T., Reymond A. and Antonarakis S.E. (2005). Conserved non-genic sequences-an unexpected feature of mammalian genomes. Nat. Rev. Genet. 6, 151-157.
17. Diez O., Osorio A., Duran M., Martinez-Ferrandis J.I., de la Hoya M., Salazar R., Vega A., Campos B., Rodriguez-Lopez R., Velasco E., Chaves J., Diaz-Rubio E., Jesus Cruz J., Torres M., Esteban E., Cervantes A., Alonso C., San Roman J.M., Gonzalez-Sarmiento R., Miner C., Carracedo A., Armengod M.E., Caldes T., Benitez J. and Baiget M. (2003). Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum. Mutat. 22, 301-312.
18. Drake J.A., Bird C., Nemesh J., Thomas D.J., Newton-Cheh C., Reymond A., Excoffier L., Attar H., Antonarakis S.E., Dermitzakis E.T. and Hirschhorn J.N. (2006). Conserved noncoding sequences are selectively constrained and not mutation cold spots. Nat. Genet. 38, 223-227.
19. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C.S., Bowman R., the SEARCH collaborators, Meyer K.B., Haiman C.A., Kolonel L.K., Henderson B.E., Le Marchand L., Brennan P., Sangrajrang S., Gaborieau V., Odefrey F., Shen C.Y., Wu P.E., Wang H.C., Eccles D., Evans D.G., Peto J., Fletcher O., Johnson N., Seal S., Stratton M.R., Rahman N., Chenevix-Trench G., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Garcia-Closas M., Brinton L., Chanock S., Lissowska J., Peplonska B., Nevanlinna H., Fagerholm R., Eerola H., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Hunter D.J., Hankinson S.E., Cox D.G., Hall P., Wedren S., Liu J., Low Y.L., Bogdanova N., Schurmann P., Dork T., Tollenaar R.A., Jacobi C.E., Devilee P., Klijn J.G., Sigurdson A.J., Doody M.M., Alexander B.H., Zhang J., Cox A., Brock I.W., Macpherson G., Reed M.W., Couch F.J., Goode E.L., Olson J.E., Meijers-Heijboer H., van den Ouweland A., Uitterlinden A., Rivadeneira F., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Hopper J.L., McCredie M., Southey M., Giles G.G., Schroen C., Justenhoven C., Brauch H., Hamann U., Ko Y.D., Spurdle A.B., Beesley J., Chen X., kConFab, AOCS Management Group, Mannermaa A., Kosma V.M., Kataja V., Hartikainen J., Day N.E., Cox D.R. and Ponder B.A. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093.
20. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M. and Kolodner R. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027-1038.
21. Gudmundsson J., Sulem P., Manolescu A., Amundadottir L.T., Gudbjartsson D., Helgason A., Rafnar T., Bergthorsson J.T., Agnarsson B.A., Baker A., Sigurdsson A., Benediktsdottir K.R., Jakobsdottir M., Xu J., Blondal T., Kostic J., Sun J, Ghosh S, Stacey S. N, Mouy M., Saemundsdottir J., Backman V.M., Kristjansson K., Tres A., Partin A.W., Albers-Akkers M.T., Godino-Ivan Marcos J., Walsh P.C., Swinkels D.W., Navarrete S., Isaacs S.D., Aben K.K., Graif T., Cashy J., Ruiz-Echarri M., Wiley K.E., Suarez B.K., Witjes J.A., Frigge M., Ober C., Jonsson E., Einarsson G.V., Mayordomo J.I., Kiemeney L.A., Isaacs W.B., Catalona W.J., Barkardottir R.B., Gulcher J.R., Thorsteinsdottir U., Kong A. and Stefansson K. (2007). Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631-637.
22. Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey B. and King M.C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689.
23. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., Albrecht M., Mayr G., De La Vega F.M., Briggs J., Gunther S., Prescott N.J., Onnie C.M., Hasler R., Sipos B., Folsch U.R., Lengauer T., Platzer M., Mathew C.G., Krawczak M. and Schreiber S. (2007). A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211.
24. Hao K., Wang X., Niu T., Xu X., Li A., Chang W., Wang L., Li G. and Laird N. (2004). A candidate gene association study on preterm delivery: application of high-throughput genotyping technology and advanced statistical methods. Hum. Mol. Genet. 13, 683-691.
25. Hirschhorn J.N. and Daly M.J. (2005). Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108.
26. Holland E.A., Beaton S.C., Becker T.M., Grulet O.M., Peters B.A., Rizos H., Kefford R.F. and Mann G.J. (1995). Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 11, 2289-2294.
27. Houlston R.S. and Peto J. (2003). The future of association studies of common cancers. Hum. Genet. 112, 434-435.
28. Houlston R.S. and Peto J. (2004). The search for low-penetrance cancer susceptibility alleles. Oncogene 23, 6471-6476.
29. Hu N., Wang C., Hu Y., Yang H.H., Giffen C., Tang Z.Z., Han X.Y., Goldstein A.M., Emmert-Buck M.R., Buetow K.H., Taylor P.R. and Lee MP. (2005). Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res. 65, 2542-2546.
30. Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., Wacholder S., Wang Z., Welch R., Hutchinson A., Wang J., Yu K., Chatterjee N., Orr N., Willett W.C., Colditz G.A., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Hayes R.B., Tucker M., Gerhard D.S., Fraumeni J.F. Jr, Hoover R.N., Thomas G. and Chanock S.J. (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874.
31. Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N.A., Ding W., Hussey C., Tran T., Miki Y., Weaver-Feldhaus J., McClure M., Aitken J.F., Anderson D.E., Bergman M., Frants R., Goldgar D.E., Green A., MacLennan R., Martin N.G., Meyer L.J., Youl P., Zone J.J., Skolnick M.H. and Cannon-Albright L.A. (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8, 23-26.
32. Kammerer S., Roth R.B., Reneland R., Marnellos G., Hoyal C.R., Markward N.J., Ebner F,. Kiechle M., Schwarz-Boeger U., Griffiths L.R., Ulbrich C., Chrobok K., Forster G., Praetorius G.M., Meyer P., Rehbock J., Cantor C.R., Nelson M.R. and Braun A. (2004). Largescale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 64, 8906-8910.
33. Kawada N., Moriyama T., Ando A., Koyama T., Hori M., Miwa T. and Imai E. (1999). Role of intron 1 in smooth muscle alpha-actin transcriptional regulation in activated mesangial cells in vivo. Kidney Int. 55, 2338-2348.
34. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V. and Gottesman M.M. (2007). A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315, 525-528.
35. Lesueur F., Pharoah P.D., Laing S., Ahmed S., Jordan C., Smith P.L., Luben R., Wareham N.J., Easton D.F., Dunning A.M. and Ponder B.A. (2005). Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Hum. Mol. Genet. 14, 2349-2356.
36. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S., Hinrichs A.L., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Gogic G., Chan J., Cravchik A., Ross D., Lau K., Kwok S., Chang S.Y., Catanese J., Sninsky J., White T.J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Owen M., Williams J., Goate A. and Grupe A. (2004). Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. USA 101, 15688-15693.
37. Lindblom A., Tannergard P., Werelius B. and Nordenskjold M. (1993). Genetic mapping of a second locus predisposing to hereditary nonpolyposis colon cancer. Nat. Genet. 5, 279-282.
38. Mathew C.G., Chin K.S., Easton D.F., Thorpe K., Carter C., Liou G.I., Fong S.L., Bridges C.D., Haak H., Kruseman A.C., Schifter S., Hansen H.H., Telenius H., Telenius-Berg M. and Ponder B.A.J. (1987). A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328, 527-528.
39. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P., Norris F., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A. and Skolnick M.H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
40. Milne R.L., Ribas G., Gonzalez-Neira A., Fagerholm R., Salas A., Gonzalez E., Dopazo J., Nevanlinna H., Robledo M. and Benitez J. (2006). ERCC4 associated with breast cancer risk: A two-stage case-control study using high-throughput genotyping. Cancer Res. 66, 9420-9427.
41. Mulligan L.M., Kwok J.B., Healey C.S., Elsdon M.J., Eng C., Gardner E., Love D.R., Mole S.E., Moore J.K., Papi L., Ponder M.A., Telenius H., Tunnacliffe A. and Ponder B.A.J. (1993). Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460.
42. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W. and Diatchenko L. (2006). Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314, 1930-1933.
43. Narod S.A., Feunteun J., Lynch H.T., Watson P., Conway T., Lynch J. and Lenoir G.M. (1991). Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338, 82-83.
44. Neale B.M. and Sham P.C. (2004). The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75, 353-362.
45. Nystrom-Lahti M., Sistonen P., Mecklin J.P., Pylkkanen L., Aaltonen L.A., Jarvinen H., Weissenbach J., de la Chapelle A. and Peltomaki P. (1994). Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc. Natl. Acad. Sci. USA. 91, 6054-6058.
46. Ozaki K. and Tanaka T. (2005). Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol. Life. Sci. 62, 1804-1813.
47. Peltomaki P., Aaltonen L.A., Sistonen P., Pylkkanen L., Mecklin J.P., Jarvinen H., Green J.S., Jass J. R, Weber J.L., Leach F.S., Petersen G.M., Hamilton S.R., de la Chapelle A. and Vogelstein B. (1993). Genetic mapping of a locus predisposing to human colorectal cancer. Science 260, 810-812.
48. Peters E.J., Slager S.L., McGrath P.J., Knowles J.A. and Hamilton S.P. (2004). Investigation of serotonin-related genes in antidepressant response. Mol. Psychiatry 9, 879-889.
49. Pharoah P.D., Antoniou A., Bobrow M., Zimmern R.L., Easton D.F. and Ponder B.A. (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33-36.
50. Pharoah P.D., Dunning A.M., Ponder B.A. and Easton D.F. (2004). Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 4, 850-860.
51. Risch N. and Merikangas K. (1996). The future of genetic studies of complex human diseases. Science 273, 1516-1517.
52. Risch N.J. (2000). Searching for genetic determinants in the new millennium. Nature 405, 847-856.
53. Shiffman D., Ellis S.G., Rowland C.M., Malloy M.J., Luke M.M., Iakoubova O.A., Pullinger C.R., Cassano J., Aouizerat B.E., Fenwick R.G., Reitz R.E., Catanese J.J., Leong D.U., Zellner C., Sninsky J.J., Topol E.J., Devlin J.J. and Kane J.P. (2005). Identification of four gene variants associated with myocardial infarction. Am. J. Hum. Genet. 77, 596-605.
54. Simpson N.E., Kidd K.K., Goodfellow P.J., McDermid H., Myers S., Kidd J.R., Jackson C.E., Duncan A.M., Farrer L.A., Brasch K., Castiglione C., Genel M., Gertner J., Greenberg C.R., Gusella J.F., Holden J.J.A. and White B.N. (1987). Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328, 528-530.
55. Song H., Ramus S.J., Kjaer S.K., Hogdall E., Dicioccio R.A., Whittemore A.S., McGuire V., Hogdall C., Jacobs I.J., Easton D.F., Ponder B.A., Dunning A.M., Gayther S.A. and Pharoah P.D. (2007). Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer. PLoS ONE. 2, e268.
56. Song H., Ramus S.J., Quaye L., DiCioccio R.A., Tyrer J., Lomas E., Shadforth D., Hogdall E., Hogdall C., McGuire V., Whittemore A.S., Easton D.F., Ponder B.A., Kjaer S.K., Pharoah P.D. and Gayther S.A. (2006a). Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 27, 2235-2242.
57. Song H., Ramus S.J., Shadforth D., Quaye L., Kjaer S.K., Dicioccio R.A., Dunning A.M., Hogdall E., Hogdall C., Whittemore A.S., McGuire V., Lesueur F., Easton D.F., Jacobs I.J., Ponder B.A., Gayther S.A. and Pharoah P.D. (2006b). Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Res. 66, 10220-10226.
58. Stacey S.N., Manolescu A., Sulem P., Rafnar T., Gudmundsson J., Gudjonsson S.A., Masson G., Jakobsdottir M., Thorlacius S., Helgason A., Aben K.K., Strobbe L.J., Albers-Akkers M.T., Swinkels D.W., Henderson B.E., Kolonel L.N., Le Marchand L., Millastre E., Andres R., Godino J., Garcia-Prats M.D., Polo E., Tres A., Mouy M., Saemundsdottir J., Backman V.M., Gudmundsson L., Kristjansson K., Bergthorsson J.T., Kostic J., Frigge M.L., Geller F., Gudbjartsson D., Sigurdsson H., Jonsdottir T., Hrafnkelsson J., Johannsson J., Sveinsson T., Myrdal G., Grimsson H.N., Jonsson T., von Holst S., Werelius B., Margolin S., Lindblom A., Mayordomo J.I., Haiman C.A., Kiemeney L.A., Johannsson O.T., Gulcher J.R., Thorsteinsdottir U., Kong A. and Stefansson K. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 39, 865-869.
59. The Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
60. Thompson D. and Easton D. (2004). The genetic epidemiology of breast cancer genes. J. Mammary Gland Biol. Neoplasia 9, 221-236.
61. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L. and Rothman N. (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96, 434-442.
62. Wang W.Y., Barratt B.J., Clayton D.G. and Todd J.A. (2005). Genomewide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109-118.
63. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C. and Micklem G. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.
64. Wooster R., Neuhausen S.L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D., Fields P., Marshall G., Narod S., Lenoir G.M., Lynch H., Feunteun J., Devilee P., Cornelisse C.J., Menko F.H., Daly P.A., Ormiston W., McManus R., Pye C., Lewis C.M., Cannon-Albright L.A., Peto J., Ponder B.A.J., Skolnick M.H., Easton D.F., Goldgar D.E. and Stratton M.R. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090.
65. Wu X., Gu J., Grossman H.B., Amos C.I., Etzel C., Huang M., Zhang Q., Millikan R.E., Lerner S., Dinney C.P. and Spitz M.R. (2006). Bladder cancer predisposition: a multigenic approach to DNA-repair and cellcycle-control genes. Am. J. Hum. Genet. 78, 464-479.
66. Yeager M., Orr N., Hayes R.B., Jacobs K.B., Kraft P., Wacholder S., Minichiello M.J., Fearnhead P., Yu K., Chatterjee N., Wang Z., Welch R., Staats B.J., Calle E.E., Feigelson H.S., Thun M.J., Rodriguez C., Albanes D., Virtamo J., Weinstein S., Schumacher F.R., Giovannucci E., Willett W.C., Cancel-Tassin G., Cussenot O., Valeri A., Andriole G.L., Gelmann E.P., Tucker M., Gerhard D.S., Fraumeni J.F. Jr, Hoover R., Hunter D.J., Chanock S.J. and Thomas G. (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649.
67. Zondervan K.T. and Cardon L.R. (2004). The complex interplay among factors that influence allelic association. Nat. Rev. Genet. 5, 89-100.